Association of Sirtuin 1 Gene Polymorphisms with the Risk of Coronary Heart Disease in Chinese Han Patients with Type 2 Diabetes Mellitus

Yuxin Wang,Linchao Tong,Nan Gu,Xiaowei Ma,Difei Lu,Dahong Yu,Na Yu,Junqing Zhang,Jianping Li,Xiaohui Guo
DOI: https://doi.org/10.1155/2022/8494502
IF: 4.0608
2022-04-16
Journal of Diabetes Research
Abstract:Aims. To explore the associations between polymorphisms in SIRT1 and coronary heart disease (CHD) risk in Chinese Han patients with type 2 diabetes (T2D). Methods. This case-controlled study enrolled 492 patients with T2D: 297 with CHD and 195 without CHD. Five SIRT1 haplotype-tagging single-nucleotide polymorphisms (rs3818291, rs12242965, rs3818292, rs4746720, and rs16924934) were selected from Chinese Han data in the GRCh37.p13 phase 3 database and genotyped by polymerase chain reaction-restriction fraction length polymorphism or sequencing. Results. The rs16924934 G allele was associated with a higher risk of CHD than the A allele (odds ratio OR = 1.429 ; 95% confidence interval CI = 1.003 – 2.037 ; P = 0.048 ). Using an additive inheritance model, the rs3818291 G/A genotype was associated with a higher CHD risk than the G/G genotype ( OR ’ = 1.683 ; 95 % CI = 1.033 – 2.743 ; P ’ = 0.037 after adjustment for CHD risk factors). Smokers carrying G/A or A/A rs3818291 genotypes had a 3-fold higher CHD risk than those carrying GG (adjusted OR ’ = 3.035 ; P ’ = 0.011 ) and a 2.6-fold higher CHD risk than nonsmokers carrying GG (adjusted OR ’ = 2.604 ; P ’ = 0.033 ). Conclusions. Genetic polymorphisms of SIRT1 are associated with the risk of CHD in a Chinese Han population with T2D.
endocrinology & metabolism,medicine, research & experimental
What problem does this paper attempt to address?
This paper aims to explore the association between SIRT1 gene polymorphisms and the risk of coronary heart disease (CHD) in Chinese Han patients with type 2 diabetes mellitus (T2D). Specifically, the researchers selected five SIRT1 single - nucleotide polymorphism (SNP) loci (rs3818291, rs12242965, rs3818292, rs4746720, and rs16924934), and through a case - control study design, evaluated whether these polymorphisms were associated with the CHD risk in T2D patients. The main findings of the study include: - The rs16924934 G allele was associated with a higher CHD risk (odds ratio \(OR = 1.429\), 95% confidence interval \(95\% CI= 1.003 - 2.037\), \(P = 0.048\)). - Using the additive genetic model, compared with the G/G genotype, the rs3818291 G/A genotype was associated with a higher CHD risk (adjusted \(OR'= 1.683\), 95% confidence interval \(95\% CI = 1.033 - 2.743\), \(P'= 0.037\)). - The CHD risk of smokers carrying the rs3818291 G/A or A/A genotype was three times that of non - smokers carrying the G/G genotype (adjusted \(OR'= 3.035\), \(P'= 0.011\)), and 2.6 times that of non - smokers not carrying the G/G genotype (adjusted \(OR'= 2.604\), \(P'= 0.033\)). In conclusion, this study shows that SIRT1 gene polymorphisms may affect the CHD risk in Chinese Han patients with type 2 diabetes mellitus, especially for smokers or overweight/obese patients, which provides potential biomarkers for the early screening of high - risk patients.